These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7734367)

  • 1. Low-dose cladribine for symptomatic hairy cell leukaemia.
    Juliusson G; Lenkei R; Tjønnfjord G; Heldal D; Liliemark J
    Br J Haematol; 1995 Mar; 89(3):637-9. PubMed ID: 7734367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factor.
    Juliusson G; Lenkei R; Tjønnfjord G; Heldal D; Liliemark J
    Ann Oncol; 1995 Apr; 6(4):371-5. PubMed ID: 7619752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
    Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F
    Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia.
    Tadmor T; Levy I; Herishanu Y; Goldschmidt N; Bairey O; Yuklea M; Shvidel L; Fineman R; Aviv A; Ruchlemer R; Braester A; Dally N; Rouvio O; Shaulov A; Greenbaum U; Inbar M; Polliack A
    Leuk Res; 2019 Jul; 82():24-28. PubMed ID: 31152919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of skin rash in patients with hairy cell leukemia treated with cladribine.
    Ganzel C; Gatt ME; Maly A; Ben-Yehuda D; Goldschmidt N
    Leuk Lymphoma; 2012 Jun; 53(6):1169-73. PubMed ID: 22035415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hairy cell leukemia treated with cladribine].
    Ghanima W; Heldal D; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1094-7. PubMed ID: 12043051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine.
    Tousi B; D'Silva R; Papish S
    Clin Lab Haematol; 2002 Aug; 24(4):259-60. PubMed ID: 12181031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia.
    Saven A; Burian C; Adusumalli J; Koziol JA
    Blood; 1999 Apr; 93(8):2471-7. PubMed ID: 10194424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.
    Juliusson G; Heldal D; Hippe E; Hedenus M; Malm C; Wallman K; Stolt CM; Evensen SA; Albertioni F; Tjønnfjord G
    J Clin Oncol; 1995 Apr; 13(4):989-95. PubMed ID: 7707128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia.
    Tallman MS; Hakimian D; Variakojis D; Koslow D; Sisney GA; Rademaker AW; Rose E; Kaul K
    Blood; 1992 Nov; 80(9):2203-9. PubMed ID: 1358262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.
    von Rohr A; Schmitz SF; Tichelli A; Hess U; Piguet D; Wernli M; Frickhofen N; Konwalinka G; Zulian G; Ghielmini M; Rufener B; Racine C; Fey MF; Cerny T; Betticher D; Tobler A;
    Ann Oncol; 2002 Oct; 13(10):1641-9. PubMed ID: 12377655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hairy cell leukemia with cladribine].
    Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
    Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cladribine in the treatment of hairy-cell leukaemia.
    Goodman GR; Beutler E; Saven A
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):101-16. PubMed ID: 12670469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.
    Dinçol G; Kahraman R
    Am J Hematol; 2006 May; 81(5):387. PubMed ID: 16628737
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.
    Hoffman MA; Janson D; Rose E; Rai KR
    J Clin Oncol; 1997 Mar; 15(3):1138-42. PubMed ID: 9060556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hairy cell leukemia-variant with cladribine.
    Tetreault SA; Robbins BA; Saven A
    Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Outcomes Of Patients With Hairy Cell Leukaemia; A 16-Year Experience At A Tertiary Care Center In Pakistan.
    Yousaf M; Khan MA; Iftikhar R; Chaudary QU; Shahbaz N; Ahmad U; Javed H
    J Ayub Med Coll Abbottabad; 2022; 34(4):797-801. PubMed ID: 36566402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.